BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Werewolf Therapeutics Reports First Quarter 2024 Financial Results and[...]
04/19/2024 | Press release | Distributed by Public on 04/19/2024 11:46
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact